nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—kidney cancer	0.186	1	CrCtD
Epirubicin—Anthracyclines—Doxorubicin—kidney cancer	0.151	0.657	CiPCiCtD
Epirubicin—AURKA—kidney cancer	0.107	1	CbGaD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.0791	0.343	CiPCiCtD
Epirubicin—Valrubicin—Doxorubicin—kidney cancer	0.0393	0.333	CrCrCtD
Epirubicin—Idarubicin—Doxorubicin—kidney cancer	0.0393	0.333	CrCrCtD
Epirubicin—Daunorubicin—Doxorubicin—kidney cancer	0.0393	0.333	CrCrCtD
Epirubicin—thyroid cancer—kidney cancer	0.0346	0.19	CtDrD
Epirubicin—liver cancer—kidney cancer	0.0334	0.183	CtDrD
Epirubicin—urinary bladder cancer—kidney cancer	0.0268	0.147	CtDrD
Epirubicin—bone cancer—kidney cancer	0.0257	0.141	CtDrD
Epirubicin—YWHAG—Doxorubicin—kidney cancer	0.0251	0.239	CbGbCtD
Epirubicin—AURKA—Doxorubicin—kidney cancer	0.0251	0.239	CbGbCtD
Epirubicin—DHCR7—Doxorubicin—kidney cancer	0.0251	0.239	CbGbCtD
Epirubicin—pancreatic cancer—kidney cancer	0.0227	0.124	CtDrD
Epirubicin—testicular cancer—kidney cancer	0.0213	0.117	CtDrD
Epirubicin—sarcoma—kidney cancer	0.0181	0.0991	CtDrD
Epirubicin—ABCC1—Dactinomycin—kidney cancer	0.00735	0.07	CbGbCtD
Epirubicin—ABCC1—Paclitaxel—kidney cancer	0.00525	0.05	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—kidney cancer	0.0051	0.0486	CbGbCtD
Epirubicin—ABCC1—Vinblastine—kidney cancer	0.0046	0.0438	CbGbCtD
Epirubicin—ABCC1—Vincristine—kidney cancer	0.00453	0.0431	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—kidney cancer	0.00283	0.0269	CbGbCtD
Epirubicin—CHD1—nephron tubule—kidney cancer	0.000597	0.0779	CbGeAlD
Epirubicin—CHD1—cortex of kidney—kidney cancer	0.000511	0.0667	CbGeAlD
Epirubicin—CHD1—gonad—kidney cancer	0.000487	0.0635	CbGeAlD
Epirubicin—CHD1—cardiac atrium—kidney cancer	0.000486	0.0634	CbGeAlD
Epirubicin—AURKA—renal system—kidney cancer	0.000437	0.0571	CbGeAlD
Epirubicin—AURKA—kidney—kidney cancer	0.000423	0.0552	CbGeAlD
Epirubicin—DHCR7—nephron tubule—kidney cancer	0.000402	0.0525	CbGeAlD
Epirubicin—AURKA—gonad—kidney cancer	0.000392	0.0512	CbGeAlD
Epirubicin—DHCR7—cortex of kidney—kidney cancer	0.000344	0.045	CbGeAlD
Epirubicin—YWHAG—renal system—kidney cancer	0.000336	0.0438	CbGeAlD
Epirubicin—DHCR7—gonad—kidney cancer	0.000328	0.0428	CbGeAlD
Epirubicin—DHCR7—cardiac atrium—kidney cancer	0.000328	0.0428	CbGeAlD
Epirubicin—Doxorubicin—AURKA—kidney cancer	0.000327	0.658	CrCbGaD
Epirubicin—YWHAG—kidney—kidney cancer	0.000325	0.0424	CbGeAlD
Epirubicin—YWHAG—cortex of kidney—kidney cancer	0.000316	0.0413	CbGeAlD
Epirubicin—UGT2B7—renal system—kidney cancer	0.000303	0.0396	CbGeAlD
Epirubicin—YWHAG—gonad—kidney cancer	0.000301	0.0393	CbGeAlD
Epirubicin—YWHAG—cardiac atrium—kidney cancer	0.000301	0.0393	CbGeAlD
Epirubicin—UGT2B7—kidney—kidney cancer	0.000293	0.0383	CbGeAlD
Epirubicin—PLA2G4A—renal system—kidney cancer	0.00025	0.0327	CbGeAlD
Epirubicin—PLA2G4A—cortex of kidney—kidney cancer	0.000236	0.0308	CbGeAlD
Epirubicin—ABCC1—cortex of kidney—kidney cancer	0.000135	0.0176	CbGeAlD
Epirubicin—ABCC1—cardiac atrium—kidney cancer	0.000128	0.0167	CbGeAlD
Epirubicin—Daunorubicin—CYP1A1—kidney cancer	8.65e-05	0.174	CrCbGaD
Epirubicin—AURKA—Sirolimus—Everolimus—kidney cancer	8.11e-05	0.107	CbGdCrCtD
Epirubicin—AURKA—Sirolimus—Temsirolimus—kidney cancer	8.11e-05	0.107	CbGdCrCtD
Epirubicin—AURKA—Temsirolimus—Everolimus—kidney cancer	8.11e-05	0.107	CbGdCrCtD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—kidney cancer	7.94e-05	0.105	CbGdCrCtD
Epirubicin—CHD1—Idarubicin—Doxorubicin—kidney cancer	7.94e-05	0.105	CbGdCrCtD
Epirubicin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	6.45e-05	0.085	CbGdCrCtD
Epirubicin—Daunorubicin—ABCB1—kidney cancer	4.6e-05	0.0926	CrCbGaD
Epirubicin—Doxorubicin—ABCB1—kidney cancer	3.73e-05	0.0752	CrCbGaD
Epirubicin—TOP2A—Vindesine—Vincristine—kidney cancer	3.28e-05	0.0432	CbGdCrCtD
Epirubicin—TOP2A—Vindesine—Vinblastine—kidney cancer	3.28e-05	0.0432	CbGdCrCtD
Epirubicin—TOP2A—Gefitinib—Erlotinib—kidney cancer	3.09e-05	0.0407	CbGdCrCtD
Epirubicin—AURKA—Cytarabine—Gemcitabine—kidney cancer	3.04e-05	0.0401	CbGdCrCtD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—kidney cancer	2.61e-05	0.0344	CbGdCrCtD
Epirubicin—AURKA—Idarubicin—Doxorubicin—kidney cancer	2.61e-05	0.0344	CbGdCrCtD
Epirubicin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	2.07e-05	0.0273	CbGdCrCtD
Epirubicin—TOP2A—Vinorelbine—Vincristine—kidney cancer	2.07e-05	0.0273	CbGdCrCtD
Epirubicin—TOP2A—Vincristine—Vinblastine—kidney cancer	1.77e-05	0.0233	CbGdCrCtD
Epirubicin—TOP2A—Vinblastine—Vincristine—kidney cancer	1.42e-05	0.0187	CbGdCrCtD
Epirubicin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	1.16e-05	0.0153	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	9.97e-06	0.0131	CbGdCrCtD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	9.97e-06	0.0131	CbGdCrCtD
Epirubicin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	8.33e-06	0.011	CbGdCrCtD
Epirubicin—UGT2B7—Metabolism—ALDH1A1—kidney cancer	6.41e-06	0.000418	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.38e-06	0.000417	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN1B—kidney cancer	6.37e-06	0.000416	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPAT—kidney cancer	6.36e-06	0.000415	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GLIPR1—kidney cancer	6.36e-06	0.000415	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDH1A1—kidney cancer	6.29e-06	0.00041	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.28e-06	0.00041	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.22e-06	0.000406	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.21e-06	0.000405	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—kidney cancer	6.16e-06	0.000402	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC5A3—kidney cancer	6.15e-06	0.000401	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PGK1—kidney cancer	6.15e-06	0.000401	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF2—kidney cancer	6.15e-06	0.000401	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ST3GAL2—kidney cancer	6.14e-06	0.000401	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.14e-06	0.000401	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.1e-06	0.000398	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND1—kidney cancer	6.08e-06	0.000397	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC5A3—kidney cancer	6.03e-06	0.000393	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LDHB—kidney cancer	6.03e-06	0.000393	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PGK1—kidney cancer	6.03e-06	0.000393	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.97e-06	0.00039	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LDHB—kidney cancer	5.91e-06	0.000386	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FH—kidney cancer	5.91e-06	0.000386	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APRT—kidney cancer	5.91e-06	0.000386	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—kidney cancer	5.88e-06	0.000384	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.84e-06	0.000381	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GPC3—kidney cancer	5.81e-06	0.000379	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CER1—kidney cancer	5.81e-06	0.000379	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.78e-06	0.000377	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—BIRC5—kidney cancer	5.75e-06	0.000375	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PGK1—kidney cancer	5.75e-06	0.000375	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC5A3—kidney cancer	5.75e-06	0.000375	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ITPR2—kidney cancer	5.74e-06	0.000374	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—PIK3CA—kidney cancer	5.69e-06	0.000372	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SFRP2—kidney cancer	5.64e-06	0.000368	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LDHB—kidney cancer	5.64e-06	0.000368	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.62e-06	0.000367	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MAPK3—kidney cancer	5.61e-06	0.000366	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPC3—kidney cancer	5.56e-06	0.000363	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.52e-06	0.00036	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—kidney cancer	5.45e-06	0.000356	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—kidney cancer	5.45e-06	0.000356	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.42e-06	0.000354	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.42e-06	0.000353	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA2—kidney cancer	5.4e-06	0.000353	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.4e-06	0.000352	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MAPK1—kidney cancer	5.33e-06	0.000348	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.32e-06	0.000347	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALAD—kidney cancer	5.27e-06	0.000344	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TCEB2—kidney cancer	5.26e-06	0.000343	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TCEB1—kidney cancer	5.26e-06	0.000343	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.24e-06	0.000342	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CA9—kidney cancer	5.23e-06	0.000341	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.17e-06	0.000337	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—kidney cancer	5.15e-06	0.000336	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ST3GAL2—kidney cancer	5.14e-06	0.000335	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CA9—kidney cancer	5.13e-06	0.000335	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.07e-06	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.06e-06	0.00033	CbGpPWpGaD
Epirubicin—Thrombocytopenia—Paclitaxel—kidney cancer	5.05e-06	0.000108	CcSEcCtD
Epirubicin—Tachycardia—Paclitaxel—kidney cancer	5.04e-06	0.000108	CcSEcCtD
Epirubicin—Rash—Sorafenib—kidney cancer	5.04e-06	0.000108	CcSEcCtD
Epirubicin—Dermatitis—Sorafenib—kidney cancer	5.03e-06	0.000108	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALDH1A1—kidney cancer	5.02e-06	0.000328	CbGpPWpGaD
Epirubicin—Back pain—Capecitabine—kidney cancer	5.02e-06	0.000107	CcSEcCtD
Epirubicin—Breast disorder—Doxorubicin—kidney cancer	5.02e-06	0.000107	CcSEcCtD
Epirubicin—Skin disorder—Paclitaxel—kidney cancer	5.01e-06	0.000107	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—MAPK3—kidney cancer	5.01e-06	0.000327	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.01e-06	0.000327	CbGpPWpGaD
Epirubicin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5e-06	0.000107	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	5e-06	0.000107	CcSEcCtD
Epirubicin—Headache—Sorafenib—kidney cancer	5e-06	0.000107	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	5e-06	0.000326	CbGpPWpGaD
Epirubicin—Muscle spasms—Capecitabine—kidney cancer	4.99e-06	0.000107	CcSEcCtD
Epirubicin—Hyperhidrosis—Paclitaxel—kidney cancer	4.99e-06	0.000107	CcSEcCtD
Epirubicin—Diarrhoea—Dactinomycin—kidney cancer	4.98e-06	0.000107	CcSEcCtD
Epirubicin—Nasopharyngitis—Doxorubicin—kidney cancer	4.97e-06	0.000106	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—SFRP2—kidney cancer	4.94e-06	0.000323	CbGpPWpGaD
Epirubicin—Anorexia—Paclitaxel—kidney cancer	4.92e-06	0.000105	CcSEcCtD
Epirubicin—Gastritis—Doxorubicin—kidney cancer	4.92e-06	0.000105	CcSEcCtD
Epirubicin—DHCR7—Metabolism—POMC—kidney cancer	4.91e-06	0.000321	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.9e-06	0.00032	CbGpPWpGaD
Epirubicin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.9e-06	0.000105	CcSEcCtD
Epirubicin—Muscular weakness—Doxorubicin—kidney cancer	4.9e-06	0.000105	CcSEcCtD
Epirubicin—Vision blurred—Capecitabine—kidney cancer	4.89e-06	0.000105	CcSEcCtD
Epirubicin—Vomiting—Sunitinib—kidney cancer	4.89e-06	0.000105	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—MYC—kidney cancer	4.88e-06	0.000318	CbGpPWpGaD
Epirubicin—Body temperature increased—Gemcitabine—kidney cancer	4.87e-06	0.000104	CcSEcCtD
Epirubicin—Rash—Sunitinib—kidney cancer	4.85e-06	0.000104	CcSEcCtD
Epirubicin—Dermatitis—Sunitinib—kidney cancer	4.84e-06	0.000104	CcSEcCtD
Epirubicin—Abdominal distension—Doxorubicin—kidney cancer	4.83e-06	0.000103	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—kidney cancer	4.83e-06	0.000315	CbGpPWpGaD
Epirubicin—Hypotension—Paclitaxel—kidney cancer	4.82e-06	0.000103	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PGK1—kidney cancer	4.82e-06	0.000314	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC5A3—kidney cancer	4.82e-06	0.000314	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Capecitabine—kidney cancer	4.82e-06	0.000103	CcSEcCtD
Epirubicin—Headache—Sunitinib—kidney cancer	4.81e-06	0.000103	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ANXA1—kidney cancer	4.81e-06	0.000314	CbGpPWpGaD
Epirubicin—Dysphagia—Doxorubicin—kidney cancer	4.8e-06	0.000103	CcSEcCtD
Epirubicin—Asthma—Doxorubicin—kidney cancer	4.8e-06	0.000103	CcSEcCtD
Epirubicin—Influenza—Doxorubicin—kidney cancer	4.8e-06	0.000103	CcSEcCtD
Epirubicin—Anaemia—Capecitabine—kidney cancer	4.8e-06	0.000103	CcSEcCtD
Epirubicin—Hypersensitivity—Vincristine—kidney cancer	4.79e-06	0.000102	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.78e-06	0.000312	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MAPK1—kidney cancer	4.77e-06	0.000311	CbGpPWpGaD
Epirubicin—Eosinophilia—Doxorubicin—kidney cancer	4.76e-06	0.000102	CcSEcCtD
Epirubicin—Nausea—Sorafenib—kidney cancer	4.74e-06	0.000102	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	4.73e-06	0.000309	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LDHB—kidney cancer	4.72e-06	0.000308	CbGpPWpGaD
Epirubicin—Pancreatitis—Doxorubicin—kidney cancer	4.71e-06	0.000101	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	4.71e-06	0.000307	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.7e-06	0.000101	CcSEcCtD
Epirubicin—Malaise—Capecitabine—kidney cancer	4.68e-06	0.0001	CcSEcCtD
Epirubicin—Angina pectoris—Doxorubicin—kidney cancer	4.68e-06	0.0001	CcSEcCtD
Epirubicin—Insomnia—Paclitaxel—kidney cancer	4.67e-06	9.99e-05	CcSEcCtD
Epirubicin—Vertigo—Capecitabine—kidney cancer	4.66e-06	9.98e-05	CcSEcCtD
Epirubicin—Asthenia—Vincristine—kidney cancer	4.66e-06	9.98e-05	CcSEcCtD
Epirubicin—Syncope—Capecitabine—kidney cancer	4.66e-06	9.96e-05	CcSEcCtD
Epirubicin—Leukopenia—Capecitabine—kidney cancer	4.65e-06	9.94e-05	CcSEcCtD
Epirubicin—Paraesthesia—Paclitaxel—kidney cancer	4.64e-06	9.92e-05	CcSEcCtD
Epirubicin—Vomiting—Dactinomycin—kidney cancer	4.63e-06	9.9e-05	CcSEcCtD
Epirubicin—Bronchitis—Doxorubicin—kidney cancer	4.62e-06	9.88e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CCND1—kidney cancer	4.61e-06	0.000301	CbGpPWpGaD
Epirubicin—Dyspnoea—Paclitaxel—kidney cancer	4.6e-06	9.85e-05	CcSEcCtD
Epirubicin—Somnolence—Paclitaxel—kidney cancer	4.59e-06	9.82e-05	CcSEcCtD
Epirubicin—Palpitations—Capecitabine—kidney cancer	4.59e-06	9.82e-05	CcSEcCtD
Epirubicin—Rash—Dactinomycin—kidney cancer	4.59e-06	9.82e-05	CcSEcCtD
Epirubicin—Nausea—Sunitinib—kidney cancer	4.56e-06	9.77e-05	CcSEcCtD
Epirubicin—Loss of consciousness—Capecitabine—kidney cancer	4.56e-06	9.76e-05	CcSEcCtD
Epirubicin—Pancytopenia—Doxorubicin—kidney cancer	4.56e-06	9.76e-05	CcSEcCtD
Epirubicin—Dyspepsia—Paclitaxel—kidney cancer	4.54e-06	9.72e-05	CcSEcCtD
Epirubicin—Cough—Capecitabine—kidney cancer	4.53e-06	9.69e-05	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	4.5e-06	0.000294	CbGpPWpGaD
Epirubicin—Dysuria—Doxorubicin—kidney cancer	4.49e-06	9.61e-05	CcSEcCtD
Epirubicin—Neutropenia—Doxorubicin—kidney cancer	4.49e-06	9.61e-05	CcSEcCtD
Epirubicin—Decreased appetite—Paclitaxel—kidney cancer	4.49e-06	9.6e-05	CcSEcCtD
Epirubicin—Hypertension—Capecitabine—kidney cancer	4.48e-06	9.59e-05	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.46e-06	9.55e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.46e-06	9.54e-05	CcSEcCtD
Epirubicin—Fatigue—Paclitaxel—kidney cancer	4.45e-06	9.52e-05	CcSEcCtD
Epirubicin—Diarrhoea—Vincristine—kidney cancer	4.45e-06	9.52e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CRABP1—kidney cancer	4.44e-06	0.00029	CbGpPWpGaD
Epirubicin—Pollakiuria—Doxorubicin—kidney cancer	4.44e-06	9.49e-05	CcSEcCtD
Epirubicin—Asthenia—Gemcitabine—kidney cancer	4.42e-06	9.47e-05	CcSEcCtD
Epirubicin—Arthralgia—Capecitabine—kidney cancer	4.42e-06	9.46e-05	CcSEcCtD
Epirubicin—Chest pain—Capecitabine—kidney cancer	4.42e-06	9.46e-05	CcSEcCtD
Epirubicin—Myalgia—Capecitabine—kidney cancer	4.42e-06	9.46e-05	CcSEcCtD
Epirubicin—Pain—Paclitaxel—kidney cancer	4.41e-06	9.45e-05	CcSEcCtD
Epirubicin—Constipation—Paclitaxel—kidney cancer	4.41e-06	9.45e-05	CcSEcCtD
Epirubicin—Anxiety—Capecitabine—kidney cancer	4.4e-06	9.42e-05	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.39e-06	0.000286	CbGpPWpGaD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.39e-06	9.39e-05	CcSEcCtD
Epirubicin—Photosensitivity reaction—Doxorubicin—kidney cancer	4.38e-06	9.38e-05	CcSEcCtD
Epirubicin—Weight increased—Doxorubicin—kidney cancer	4.37e-06	9.35e-05	CcSEcCtD
Epirubicin—Discomfort—Capecitabine—kidney cancer	4.37e-06	9.34e-05	CcSEcCtD
Epirubicin—Pruritus—Gemcitabine—kidney cancer	4.36e-06	9.34e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CRABP1—kidney cancer	4.36e-06	0.000284	CbGpPWpGaD
Epirubicin—Weight decreased—Doxorubicin—kidney cancer	4.34e-06	9.3e-05	CcSEcCtD
Epirubicin—Hyperglycaemia—Doxorubicin—kidney cancer	4.33e-06	9.27e-05	CcSEcCtD
Epirubicin—Dry mouth—Capecitabine—kidney cancer	4.32e-06	9.25e-05	CcSEcCtD
Epirubicin—Nausea—Dactinomycin—kidney cancer	4.32e-06	9.25e-05	CcSEcCtD
Epirubicin—Pneumonia—Doxorubicin—kidney cancer	4.31e-06	9.22e-05	CcSEcCtD
Epirubicin—Dizziness—Vincristine—kidney cancer	4.3e-06	9.2e-05	CcSEcCtD
Epirubicin—Infestation—Doxorubicin—kidney cancer	4.28e-06	9.16e-05	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—kidney cancer	4.28e-06	9.16e-05	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—kidney cancer	4.28e-06	9.16e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—RPL14—kidney cancer	4.27e-06	0.000279	CbGpPWpGaD
Epirubicin—Confusional state—Capecitabine—kidney cancer	4.27e-06	9.14e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	4.26e-06	0.000278	CbGpPWpGaD
Epirubicin—Feeling abnormal—Paclitaxel—kidney cancer	4.25e-06	9.1e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.25e-06	0.000277	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.25e-06	0.000277	CbGpPWpGaD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.25e-06	9.08e-05	CcSEcCtD
Epirubicin—Oedema—Capecitabine—kidney cancer	4.24e-06	9.07e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Paclitaxel—kidney cancer	4.22e-06	9.03e-05	CcSEcCtD
Epirubicin—Diarrhoea—Gemcitabine—kidney cancer	4.22e-06	9.03e-05	CcSEcCtD
Epirubicin—Renal failure—Doxorubicin—kidney cancer	4.21e-06	9.01e-05	CcSEcCtD
Epirubicin—Infection—Capecitabine—kidney cancer	4.21e-06	9.01e-05	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—kidney cancer	4.2e-06	8.98e-05	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—kidney cancer	4.17e-06	8.93e-05	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—kidney cancer	4.17e-06	8.93e-05	CcSEcCtD
Epirubicin—Shock—Capecitabine—kidney cancer	4.17e-06	8.92e-05	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—kidney cancer	4.16e-06	8.91e-05	CcSEcCtD
Epirubicin—Urinary tract infection—Doxorubicin—kidney cancer	4.16e-06	8.91e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Capecitabine—kidney cancer	4.15e-06	8.89e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Capecitabine—kidney cancer	4.15e-06	8.88e-05	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.14e-06	0.00027	CbGpPWpGaD
Epirubicin—Tachycardia—Capecitabine—kidney cancer	4.14e-06	8.85e-05	CcSEcCtD
Epirubicin—Vomiting—Vincristine—kidney cancer	4.13e-06	8.84e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ITPR2—kidney cancer	4.13e-06	0.00027	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—kidney cancer	4.13e-06	0.00027	CbGpPWpGaD
Epirubicin—Skin disorder—Capecitabine—kidney cancer	4.12e-06	8.81e-05	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—kidney cancer	4.11e-06	8.78e-05	CcSEcCtD
Epirubicin—Urticaria—Paclitaxel—kidney cancer	4.1e-06	8.78e-05	CcSEcCtD
Epirubicin—Rash—Vincristine—kidney cancer	4.1e-06	8.77e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Capecitabine—kidney cancer	4.1e-06	8.76e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CA9—kidney cancer	4.1e-06	0.000267	CbGpPWpGaD
Epirubicin—Dermatitis—Vincristine—kidney cancer	4.09e-06	8.76e-05	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—kidney cancer	4.08e-06	8.74e-05	CcSEcCtD
Epirubicin—Body temperature increased—Paclitaxel—kidney cancer	4.08e-06	8.73e-05	CcSEcCtD
Epirubicin—Abdominal pain—Paclitaxel—kidney cancer	4.08e-06	8.73e-05	CcSEcCtD
Epirubicin—Headache—Vincristine—kidney cancer	4.07e-06	8.71e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ITPR2—kidney cancer	4.05e-06	0.000264	CbGpPWpGaD
Epirubicin—Hepatobiliary disease—Doxorubicin—kidney cancer	4.05e-06	8.67e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.04e-06	0.000264	CbGpPWpGaD
Epirubicin—Epistaxis—Doxorubicin—kidney cancer	4.04e-06	8.64e-05	CcSEcCtD
Epirubicin—Anorexia—Capecitabine—kidney cancer	4.04e-06	8.64e-05	CcSEcCtD
Epirubicin—Sinusitis—Doxorubicin—kidney cancer	4.02e-06	8.6e-05	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—TP53—kidney cancer	4e-06	0.000261	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4e-06	0.000261	CbGpPWpGaD
Epirubicin—Agranulocytosis—Doxorubicin—kidney cancer	4e-06	8.55e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CASP2—kidney cancer	3.98e-06	0.00026	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKAP13—kidney cancer	3.98e-06	0.00026	CbGpPWpGaD
Epirubicin—Hypotension—Capecitabine—kidney cancer	3.96e-06	8.47e-05	CcSEcCtD
Epirubicin—Vomiting—Gemcitabine—kidney cancer	3.92e-06	8.39e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—kidney cancer	3.92e-06	0.000256	CbGpPWpGaD
Epirubicin—Bradycardia—Doxorubicin—kidney cancer	3.91e-06	8.37e-05	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.91e-06	0.000255	CbGpPWpGaD
Epirubicin—Rash—Gemcitabine—kidney cancer	3.89e-06	8.32e-05	CcSEcCtD
Epirubicin—Dermatitis—Gemcitabine—kidney cancer	3.88e-06	8.31e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—ITPR2—kidney cancer	3.87e-06	0.000252	CbGpPWpGaD
Epirubicin—Haemoglobin—Doxorubicin—kidney cancer	3.86e-06	8.27e-05	CcSEcCtD
Epirubicin—Headache—Gemcitabine—kidney cancer	3.86e-06	8.27e-05	CcSEcCtD
Epirubicin—Nausea—Vincristine—kidney cancer	3.86e-06	8.26e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.86e-06	8.26e-05	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—kidney cancer	3.85e-06	8.25e-05	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—kidney cancer	3.84e-06	8.23e-05	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—kidney cancer	3.84e-06	8.23e-05	CcSEcCtD
Epirubicin—Insomnia—Capecitabine—kidney cancer	3.83e-06	8.2e-05	CcSEcCtD
Epirubicin—Hypoaesthesia—Doxorubicin—kidney cancer	3.82e-06	8.18e-05	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—kidney cancer	3.82e-06	8.16e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	3.81e-06	0.000249	CbGpPWpGaD
Epirubicin—Paraesthesia—Capecitabine—kidney cancer	3.8e-06	8.14e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Paclitaxel—kidney cancer	3.8e-06	8.14e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—MAPK3—kidney cancer	3.8e-06	0.000248	CbGpPWpGaD
Epirubicin—Urinary tract disorder—Doxorubicin—kidney cancer	3.8e-06	8.12e-05	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—kidney cancer	3.79e-06	8.1e-05	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—kidney cancer	3.78e-06	8.08e-05	CcSEcCtD
Epirubicin—Dyspnoea—Capecitabine—kidney cancer	3.78e-06	8.08e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.78e-06	0.000246	CbGpPWpGaD
Epirubicin—Urethral disorder—Doxorubicin—kidney cancer	3.77e-06	8.06e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ACHE—kidney cancer	3.77e-06	0.000246	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—kidney cancer	3.77e-06	0.000246	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.74e-06	0.000244	CbGpPWpGaD
Epirubicin—Dyspepsia—Capecitabine—kidney cancer	3.73e-06	7.98e-05	CcSEcCtD
Epirubicin—Visual impairment—Doxorubicin—kidney cancer	3.7e-06	7.93e-05	CcSEcCtD
Epirubicin—Asthenia—Paclitaxel—kidney cancer	3.7e-06	7.93e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GSTT1—kidney cancer	3.7e-06	0.000241	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ACHE—kidney cancer	3.7e-06	0.000241	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—kidney cancer	3.69e-06	0.000241	CbGpPWpGaD
Epirubicin—Decreased appetite—Capecitabine—kidney cancer	3.68e-06	7.88e-05	CcSEcCtD
Epirubicin—Nausea—Gemcitabine—kidney cancer	3.66e-06	7.84e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Capecitabine—kidney cancer	3.66e-06	7.83e-05	CcSEcCtD
Epirubicin—Fatigue—Capecitabine—kidney cancer	3.65e-06	7.82e-05	CcSEcCtD
Epirubicin—Pruritus—Paclitaxel—kidney cancer	3.65e-06	7.82e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GRB7—kidney cancer	3.64e-06	0.000238	CbGpPWpGaD
Epirubicin—Erythema multiforme—Doxorubicin—kidney cancer	3.63e-06	7.78e-05	CcSEcCtD
Epirubicin—Constipation—Capecitabine—kidney cancer	3.62e-06	7.75e-05	CcSEcCtD
Epirubicin—Pain—Capecitabine—kidney cancer	3.62e-06	7.75e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—MAPK1—kidney cancer	3.61e-06	0.000236	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	3.6e-06	0.000235	CbGpPWpGaD
Epirubicin—Eye disorder—Doxorubicin—kidney cancer	3.59e-06	7.69e-05	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—kidney cancer	3.58e-06	7.67e-05	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—kidney cancer	3.57e-06	7.63e-05	CcSEcCtD
Epirubicin—Cardiac disorder—Doxorubicin—kidney cancer	3.57e-06	7.63e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SCARB1—kidney cancer	3.57e-06	0.000233	CbGpPWpGaD
Epirubicin—Diarrhoea—Paclitaxel—kidney cancer	3.53e-06	7.56e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PTGS1—kidney cancer	3.53e-06	0.00023	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SCARB1—kidney cancer	3.5e-06	0.000228	CbGpPWpGaD
Epirubicin—Feeling abnormal—Capecitabine—kidney cancer	3.49e-06	7.47e-05	CcSEcCtD
Epirubicin—Angiopathy—Doxorubicin—kidney cancer	3.49e-06	7.46e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CRABP1—kidney cancer	3.48e-06	0.000227	CbGpPWpGaD
Epirubicin—Immune system disorder—Doxorubicin—kidney cancer	3.47e-06	7.43e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Capecitabine—kidney cancer	3.46e-06	7.41e-05	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—kidney cancer	3.46e-06	7.41e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PSMD7—kidney cancer	3.46e-06	0.000226	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS1—kidney cancer	3.46e-06	0.000226	CbGpPWpGaD
Epirubicin—Chills—Doxorubicin—kidney cancer	3.45e-06	7.38e-05	CcSEcCtD
Epirubicin—Arrhythmia—Doxorubicin—kidney cancer	3.43e-06	7.35e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTEN—kidney cancer	3.42e-06	0.000223	CbGpPWpGaD
Epirubicin—Dizziness—Paclitaxel—kidney cancer	3.41e-06	7.31e-05	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—kidney cancer	3.4e-06	7.27e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PSMD7—kidney cancer	3.4e-06	0.000222	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITPR2—kidney cancer	3.39e-06	0.000221	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RAF1—kidney cancer	3.38e-06	0.000221	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	3.38e-06	0.00022	CbGpPWpGaD
Epirubicin—Mental disorder—Doxorubicin—kidney cancer	3.37e-06	7.21e-05	CcSEcCtD
Epirubicin—Urticaria—Capecitabine—kidney cancer	3.37e-06	7.2e-05	CcSEcCtD
Epirubicin—Abdominal pain—Capecitabine—kidney cancer	3.35e-06	7.17e-05	CcSEcCtD
Epirubicin—Body temperature increased—Capecitabine—kidney cancer	3.35e-06	7.17e-05	CcSEcCtD
Epirubicin—Malnutrition—Doxorubicin—kidney cancer	3.35e-06	7.16e-05	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—kidney cancer	3.35e-06	7.16e-05	CcSEcCtD
Epirubicin—Flatulence—Doxorubicin—kidney cancer	3.3e-06	7.06e-05	CcSEcCtD
Epirubicin—Tension—Doxorubicin—kidney cancer	3.28e-06	7.03e-05	CcSEcCtD
Epirubicin—Vomiting—Paclitaxel—kidney cancer	3.28e-06	7.02e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—BCHE—kidney cancer	3.28e-06	0.000214	CbGpPWpGaD
Epirubicin—Dysgeusia—Doxorubicin—kidney cancer	3.28e-06	7.01e-05	CcSEcCtD
Epirubicin—Rash—Paclitaxel—kidney cancer	3.26e-06	6.97e-05	CcSEcCtD
Epirubicin—Dermatitis—Paclitaxel—kidney cancer	3.25e-06	6.96e-05	CcSEcCtD
Epirubicin—Nervousness—Doxorubicin—kidney cancer	3.25e-06	6.95e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC5A5—kidney cancer	3.24e-06	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMD7—kidney cancer	3.24e-06	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ITPR2—kidney cancer	3.24e-06	0.000211	CbGpPWpGaD
Epirubicin—Back pain—Doxorubicin—kidney cancer	3.24e-06	6.93e-05	CcSEcCtD
Epirubicin—Headache—Paclitaxel—kidney cancer	3.23e-06	6.92e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CCND1—kidney cancer	3.22e-06	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BCHE—kidney cancer	3.22e-06	0.00021	CbGpPWpGaD
Epirubicin—Muscle spasms—Doxorubicin—kidney cancer	3.22e-06	6.88e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—SLC5A5—kidney cancer	3.18e-06	0.000207	CbGpPWpGaD
Epirubicin—Vision blurred—Doxorubicin—kidney cancer	3.15e-06	6.75e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC2A1—kidney cancer	3.13e-06	0.000204	CbGpPWpGaD
Epirubicin—Hypersensitivity—Capecitabine—kidney cancer	3.12e-06	6.68e-05	CcSEcCtD
Epirubicin—Ill-defined disorder—Doxorubicin—kidney cancer	3.1e-06	6.64e-05	CcSEcCtD
Epirubicin—Anaemia—Doxorubicin—kidney cancer	3.09e-06	6.62e-05	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—kidney cancer	3.08e-06	6.58e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNA1—kidney cancer	3.07e-06	0.0002	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A1—kidney cancer	3.07e-06	0.0002	CbGpPWpGaD
Epirubicin—Nausea—Paclitaxel—kidney cancer	3.07e-06	6.56e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—EIF4EBP1—kidney cancer	3.05e-06	0.000199	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HSPB1—kidney cancer	3.05e-06	0.000199	CbGpPWpGaD
Epirubicin—Asthenia—Capecitabine—kidney cancer	3.04e-06	6.5e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—kidney cancer	3.03e-06	0.000198	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—kidney cancer	3.03e-06	0.000198	CbGpPWpGaD
Epirubicin—Malaise—Doxorubicin—kidney cancer	3.02e-06	6.46e-05	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—kidney cancer	3.01e-06	6.43e-05	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—kidney cancer	3e-06	6.42e-05	CcSEcCtD
Epirubicin—Pruritus—Capecitabine—kidney cancer	3e-06	6.41e-05	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—kidney cancer	3e-06	6.41e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.98e-06	0.000195	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.98e-06	0.000194	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.97e-06	0.000194	CbGpPWpGaD
Epirubicin—Palpitations—Doxorubicin—kidney cancer	2.96e-06	6.33e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ACHE—kidney cancer	2.95e-06	0.000193	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—kidney cancer	2.95e-06	0.000193	CbGpPWpGaD
Epirubicin—Loss of consciousness—Doxorubicin—kidney cancer	2.94e-06	6.29e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—SLC2A1—kidney cancer	2.93e-06	0.000191	CbGpPWpGaD
Epirubicin—Cough—Doxorubicin—kidney cancer	2.92e-06	6.25e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—JUNB—kidney cancer	2.91e-06	0.00019	CbGpPWpGaD
Epirubicin—Convulsion—Doxorubicin—kidney cancer	2.9e-06	6.2e-05	CcSEcCtD
Epirubicin—Diarrhoea—Capecitabine—kidney cancer	2.9e-06	6.2e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	2.89e-06	0.000189	CbGpPWpGaD
Epirubicin—Hypertension—Doxorubicin—kidney cancer	2.89e-06	6.18e-05	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—kidney cancer	2.85e-06	6.1e-05	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—kidney cancer	2.85e-06	6.1e-05	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—kidney cancer	2.85e-06	6.1e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ANXA1—kidney cancer	2.84e-06	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMD7—kidney cancer	2.84e-06	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TSC1—kidney cancer	2.84e-06	0.000185	CbGpPWpGaD
Epirubicin—Anxiety—Doxorubicin—kidney cancer	2.84e-06	6.07e-05	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.83e-06	6.05e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.83e-06	0.000184	CbGpPWpGaD
Epirubicin—Discomfort—Doxorubicin—kidney cancer	2.81e-06	6.02e-05	CcSEcCtD
Epirubicin—Dizziness—Capecitabine—kidney cancer	2.8e-06	5.99e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—SCARB1—kidney cancer	2.79e-06	0.000182	CbGpPWpGaD
Epirubicin—Dry mouth—Doxorubicin—kidney cancer	2.79e-06	5.96e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PTGS1—kidney cancer	2.77e-06	0.000181	CbGpPWpGaD
Epirubicin—Confusional state—Doxorubicin—kidney cancer	2.75e-06	5.89e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—FLT1—kidney cancer	2.75e-06	0.000179	CbGpPWpGaD
Epirubicin—Oedema—Doxorubicin—kidney cancer	2.73e-06	5.84e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Doxorubicin—kidney cancer	2.73e-06	5.84e-05	CcSEcCtD
Epirubicin—Infection—Doxorubicin—kidney cancer	2.71e-06	5.81e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PSMD7—kidney cancer	2.71e-06	0.000177	CbGpPWpGaD
Epirubicin—Vomiting—Capecitabine—kidney cancer	2.69e-06	5.76e-05	CcSEcCtD
Epirubicin—Shock—Doxorubicin—kidney cancer	2.69e-06	5.75e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—kidney cancer	2.68e-06	5.73e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Doxorubicin—kidney cancer	2.67e-06	5.72e-05	CcSEcCtD
Epirubicin—Rash—Capecitabine—kidney cancer	2.67e-06	5.72e-05	CcSEcCtD
Epirubicin—Dermatitis—Capecitabine—kidney cancer	2.67e-06	5.71e-05	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—kidney cancer	2.67e-06	5.7e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—MAPK3—kidney cancer	2.66e-06	0.000173	CbGpPWpGaD
Epirubicin—Headache—Capecitabine—kidney cancer	2.65e-06	5.68e-05	CcSEcCtD
Epirubicin—Skin disorder—Doxorubicin—kidney cancer	2.65e-06	5.68e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—kidney cancer	2.64e-06	5.65e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—GSTP1—kidney cancer	2.61e-06	0.00017	CbGpPWpGaD
Epirubicin—Anorexia—Doxorubicin—kidney cancer	2.6e-06	5.57e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.6e-06	0.00017	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—kidney cancer	2.58e-06	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—kidney cancer	2.58e-06	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BCHE—kidney cancer	2.57e-06	0.000168	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—kidney cancer	2.56e-06	0.000167	CbGpPWpGaD
Epirubicin—Hypotension—Doxorubicin—kidney cancer	2.55e-06	5.46e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—JUNB—kidney cancer	2.55e-06	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PAK1—kidney cancer	2.55e-06	0.000166	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC5A5—kidney cancer	2.54e-06	0.000166	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK1—kidney cancer	2.53e-06	0.000165	CbGpPWpGaD
Epirubicin—Nausea—Capecitabine—kidney cancer	2.52e-06	5.38e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.49e-06	5.32e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ABCB1—kidney cancer	2.47e-06	0.000161	CbGpPWpGaD
Epirubicin—Insomnia—Doxorubicin—kidney cancer	2.47e-06	5.29e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—SLC2A1—kidney cancer	2.45e-06	0.00016	CbGpPWpGaD
Epirubicin—Paraesthesia—Doxorubicin—kidney cancer	2.45e-06	5.25e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MAPK3—kidney cancer	2.44e-06	0.000159	CbGpPWpGaD
Epirubicin—Dyspnoea—Doxorubicin—kidney cancer	2.43e-06	5.21e-05	CcSEcCtD
Epirubicin—Somnolence—Doxorubicin—kidney cancer	2.43e-06	5.2e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ABCB1—kidney cancer	2.42e-06	0.000158	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—kidney cancer	2.41e-06	0.000157	CbGpPWpGaD
Epirubicin—Dyspepsia—Doxorubicin—kidney cancer	2.4e-06	5.14e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—GSTM1—kidney cancer	2.4e-06	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.38e-06	0.000155	CbGpPWpGaD
Epirubicin—Decreased appetite—Doxorubicin—kidney cancer	2.37e-06	5.08e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—CDKN2B—kidney cancer	2.37e-06	0.000154	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.36e-06	5.05e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—kidney cancer	2.35e-06	0.000154	CbGpPWpGaD
Epirubicin—Fatigue—Doxorubicin—kidney cancer	2.35e-06	5.04e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GSTM1—kidney cancer	2.35e-06	0.000154	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.34e-06	0.000153	CbGpPWpGaD
Epirubicin—Constipation—Doxorubicin—kidney cancer	2.34e-06	5e-05	CcSEcCtD
Epirubicin—Pain—Doxorubicin—kidney cancer	2.34e-06	5e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MAPK1—kidney cancer	2.32e-06	0.000151	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A1—kidney cancer	2.28e-06	0.000148	CbGpPWpGaD
Epirubicin—Feeling abnormal—Doxorubicin—kidney cancer	2.25e-06	4.82e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Doxorubicin—kidney cancer	2.23e-06	4.78e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CYP1A1—kidney cancer	2.23e-06	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—kidney cancer	2.19e-06	0.000143	CbGpPWpGaD
Epirubicin—Urticaria—Doxorubicin—kidney cancer	2.17e-06	4.64e-05	CcSEcCtD
Epirubicin—Body temperature increased—Doxorubicin—kidney cancer	2.16e-06	4.62e-05	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—kidney cancer	2.16e-06	4.62e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—TP53—kidney cancer	2.12e-06	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—kidney cancer	2.08e-06	0.000136	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.08e-06	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—kidney cancer	2.07e-06	0.000135	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—kidney cancer	2.05e-06	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1R—kidney cancer	2.01e-06	0.000131	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—kidney cancer	2.01e-06	0.000131	CbGpPWpGaD
Epirubicin—Hypersensitivity—Doxorubicin—kidney cancer	2.01e-06	4.31e-05	CcSEcCtD
Epirubicin—Asthenia—Doxorubicin—kidney cancer	1.96e-06	4.19e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—TP53—kidney cancer	1.95e-06	0.000127	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RAF1—kidney cancer	1.94e-06	0.000127	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—kidney cancer	1.94e-06	0.000126	CbGpPWpGaD
Epirubicin—Pruritus—Doxorubicin—kidney cancer	1.93e-06	4.13e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—HIF1A—kidney cancer	1.89e-06	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TSC2—kidney cancer	1.89e-06	0.000123	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—kidney cancer	1.88e-06	0.000123	CbGpPWpGaD
Epirubicin—Diarrhoea—Doxorubicin—kidney cancer	1.87e-06	4e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.83e-06	0.00012	CbGpPWpGaD
Epirubicin—Dizziness—Doxorubicin—kidney cancer	1.81e-06	3.86e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CYP1A1—kidney cancer	1.78e-06	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—kidney cancer	1.74e-06	0.000114	CbGpPWpGaD
Epirubicin—Vomiting—Doxorubicin—kidney cancer	1.74e-06	3.72e-05	CcSEcCtD
Epirubicin—Rash—Doxorubicin—kidney cancer	1.72e-06	3.68e-05	CcSEcCtD
Epirubicin—Dermatitis—Doxorubicin—kidney cancer	1.72e-06	3.68e-05	CcSEcCtD
Epirubicin—Headache—Doxorubicin—kidney cancer	1.71e-06	3.66e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—POMC—kidney cancer	1.7e-06	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—kidney cancer	1.67e-06	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KIT—kidney cancer	1.67e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—kidney cancer	1.66e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—kidney cancer	1.66e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TSC2—kidney cancer	1.65e-06	0.000108	CbGpPWpGaD
Epirubicin—Nausea—Doxorubicin—kidney cancer	1.62e-06	3.47e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—kidney cancer	1.59e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—kidney cancer	1.57e-06	0.000102	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.46e-06	9.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—kidney cancer	1.46e-06	9.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIT—kidney cancer	1.46e-06	9.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK3—kidney cancer	1.4e-06	9.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—kidney cancer	1.39e-06	9.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—kidney cancer	1.37e-06	8.96e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—kidney cancer	1.35e-06	8.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK1—kidney cancer	1.33e-06	8.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—kidney cancer	1.33e-06	8.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—kidney cancer	1.33e-06	8.66e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RAF1—kidney cancer	1.31e-06	8.54e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—kidney cancer	1.29e-06	8.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTOR—kidney cancer	1.28e-06	8.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—kidney cancer	1.28e-06	8.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—kidney cancer	1.27e-06	8.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—kidney cancer	1.26e-06	8.21e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—kidney cancer	1.2e-06	7.82e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—kidney cancer	1.18e-06	7.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—kidney cancer	1.16e-06	7.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—kidney cancer	1.16e-06	7.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAF1—kidney cancer	1.15e-06	7.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RELA—kidney cancer	1.14e-06	7.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—kidney cancer	1.13e-06	7.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—kidney cancer	1.13e-06	7.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTOR—kidney cancer	1.12e-06	7.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—kidney cancer	1.1e-06	7.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—kidney cancer	1.06e-06	6.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—kidney cancer	1.05e-06	6.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—kidney cancer	1.03e-06	6.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—kidney cancer	1e-06	6.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUN—kidney cancer	1e-06	6.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—kidney cancer	9.93e-07	6.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—kidney cancer	9.68e-07	6.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK3—kidney cancer	9.43e-07	6.16e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—kidney cancer	9.25e-07	6.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—kidney cancer	9.18e-07	5.99e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK1—kidney cancer	8.98e-07	5.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—kidney cancer	8.74e-07	5.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—kidney cancer	8.48e-07	5.53e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—kidney cancer	8.32e-07	5.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK3—kidney cancer	8.27e-07	5.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—kidney cancer	8.16e-07	5.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—kidney cancer	8.04e-07	5.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK1—kidney cancer	7.87e-07	5.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—kidney cancer	7.79e-07	5.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—kidney cancer	7.43e-07	4.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—kidney cancer	6.83e-07	4.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—kidney cancer	6.6e-07	4.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—kidney cancer	6.52e-07	4.26e-05	CbGpPWpGaD
